InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: sharinky post# 188176

Sunday, 04/21/2019 1:33:47 PM

Sunday, April 21, 2019 1:33:47 PM

Post# of 426694
They will need to raise more money if GIA, will they want more residuals from Europe and less up front? If they want a lot more money up front perhaps they can avoid dilution but think they would want bigger residual in the future with the great potential.

They compensate officers heavily with shares as the annual report states they want to align management goals with shareholders so stock options are intended to be a large portion of their earnings (Thus all the auto sells after they get them).

The filing also states they may need to raise money to market to the larger population if approved, same language used before they raised after RI results.

They will have other options to raise money, but they seem to like the shares option in the past, I would expect it again after FDA approval and be pleasantly surprised if they go a different route.

Dilution is not a bad thing in this case, gives them cash without debt, and they will get that back in spades if they use the money right but it is part of the growing pains of the GIA scenario.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News